Disseminated herpes simplex virus infection following epidermal growth factor tyrosine kinase inhibitor therapy for non-small-cell lung carcinoma

MeSH terms

• Acyclovir / analogs & derivatives
• Acyclovir / therapeutic use
• Afatinib
• Aged
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Antiviral Agents / therapeutic use
• Carcinoma, Non-Small-Cell Lung / complications
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / enzymology
• Cystitis / etiology
• Cystitis / virology
• ErbB Receptors / antagonists & inhibitors*
• Esophagitis / etiology
• Esophagitis / virology
• Hematuria / etiology
• Hematuria / virology
• Herpes Simplex / drug therapy
• Herpes Simplex / etiology*
• Humans
• Intestinal Perforation / etiology
• Intestinal Perforation / virology
• Lung Neoplasms / complications
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / enzymology
• Male
• Molecular Targeted Therapy / adverse effects*
• Neoplasm Proteins / antagonists & inhibitors*
• Peritonitis / etiology
• Protein Kinase Inhibitors / adverse effects*
• Protein Kinase Inhibitors / therapeutic use
• Quinazolines / adverse effects*
• Quinazolines / therapeutic use
• Valacyclovir
• Valine / analogs & derivatives
• Valine / therapeutic use
• Viremia / etiology
• Viremia / virology
• Virus Activation / drug effects*